Fortress Biotech, Inc. (FBIO) earnings date, results and what the price requires

    Nasdaq · SEC CIK 0001429260 · SEC filings checked Oct 17, 2026

    Next report
    Nov 13, 2026
    Estimated from reporting history (92-day cycle, SEC 8-K item 2.02 results filings). Not confirmed.
    Last close
    $1.87
    Polygon.io daily close, Oct 16, 2026. End of day, not live.
    Trailing diluted EPS
    $2.70
    Sum of quarters ending Jun 30, 2026, Mar 31, 2026, Dec 31, 2025, Sep 30, 2025 · P/E 0.7

    Previous results (SEC filings)

    Quarter endedReportedRevenueNet incomeDiluted EPSSource
    Jun 30, 2026Aug 13, 2026$18.7M$-468,000$-0.08Filing
    Mar 31, 2026May 14, 2026$16.0M$110.4M$2.82Filing
    Dec 31, 2025Mar 31, 2026$16.1M$26.2M$-0.15Filing
    Sep 30, 2025Nov 14, 2025$17.6M$5.8M$0.11Filing
    Jun 30, 2025Aug 14, 2025$16.4M$15.5M$0.45Filing
    Mar 31, 2025May 15, 2025$13.1M$-10.6M$-0.48Filing
    Dec 31, 2024Mar 31, 2025$15.1M$60.2M$-0.16Filing
    Sep 30, 2024Nov 14, 2024$14.6M$-12.9M$-0.76Filing

    What would Fortress Biotech, Inc. have to report for its valuation to change?

    At $1.87, with a 9.0% required return and a 18× earnings multiple in 5 years, earnings per share must grow about -43.2% a year, to $0.16. On that path the next quarter needs diluted EPS near $0.06, against $0.11 in the quarter ended Sep 30, 2025.

    Are you considering buying, or do you already own shares?

    Compare buying at the last close now with waiting for results: if the report moves the growth the price requires, the entry price you would accept changes with it.

    ResultOriginalYours
    Required EPS growth / year-43.2%-43.2%
    EPS needed in final year$0.16$0.16

    Changed: nothing yet. Model: EPS × (1+g)^years × final P/E, discounted at the required return, equals today's price. Inputs: SEC diluted EPS and the dated close above.

    Prepare for earnings across my investments — $399/month

    Keep working models for the companies you follow, compare your expectations with reported results, and review what changes your investment decision. FBIO goes in with your buy-or-wait comparison and assumptions preserved.

    Start Desk — $399/month

    Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.